EA201790387A1 - Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти - Google Patents

Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти

Info

Publication number
EA201790387A1
EA201790387A1 EA201790387A EA201790387A EA201790387A1 EA 201790387 A1 EA201790387 A1 EA 201790387A1 EA 201790387 A EA201790387 A EA 201790387A EA 201790387 A EA201790387 A EA 201790387A EA 201790387 A1 EA201790387 A1 EA 201790387A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pain
treatment
pharmaceutical composition
jaw
acute dental
Prior art date
Application number
EA201790387A
Other languages
English (en)
Inventor
Альберто Хегевиш
Томас Вайзер
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Санофи-Авентис Де Мексико Са Де Кв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис Дойчланд Гмбх, Санофи-Авентис Де Мексико Са Де Кв filed Critical Санофи-Авентис Дойчланд Гмбх
Publication of EA201790387A1 publication Critical patent/EA201790387A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции для перорального введения для лечения острой зубной боли или боли в челюсти, содержащей ибупрофен, кофеин и по меньшей мере один разрыхлитель.
EA201790387A 2014-08-28 2015-07-23 Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти EA201790387A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14002976 2014-08-28
PCT/EP2015/066888 WO2016030092A1 (en) 2014-08-28 2015-07-23 Pharmaceutical composition for the treatment of acute tooth or jaw pain

Publications (1)

Publication Number Publication Date
EA201790387A1 true EA201790387A1 (ru) 2017-07-31

Family

ID=51535302

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790387A EA201790387A1 (ru) 2014-08-28 2015-07-23 Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти

Country Status (11)

Country Link
US (2) US20170252346A1 (ru)
EP (1) EP3185861A1 (ru)
JP (1) JP2017525774A (ru)
CN (2) CN107205946A (ru)
AU (1) AU2015309176B2 (ru)
BR (1) BR112017003425A2 (ru)
CA (1) CA2958454A1 (ru)
EA (1) EA201790387A1 (ru)
MX (1) MX2017002700A (ru)
PH (1) PH12017500345A1 (ru)
WO (1) WO2016030092A1 (ru)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
AU5132893A (en) * 1992-09-29 1994-04-26 Mcneil-Ppc, Inc. Ibuprofen-caffeine combinations
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
JP4969747B2 (ja) * 2001-01-19 2012-07-04 武田薬品工業株式会社 錠剤フィルムコーティング用組成物
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
GB0417939D0 (en) * 2004-08-12 2004-09-15 Boots Healthcare Int Ltd Therapeutic agents
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US9066950B2 (en) * 2009-05-21 2015-06-30 Gm Pharmaceuticals, Inc. Analgesic compositions
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
WO2013031935A1 (ja) * 2011-08-31 2013-03-07 興和株式会社 安定な医薬組成物
DE202014104573U1 (de) * 2014-09-24 2014-12-05 DENK PHARMA GmbH & Co. KG Pharmazeutische Zusammensetzung zur Schmerzbehandlung

Also Published As

Publication number Publication date
AU2015309176A1 (en) 2017-03-16
CN107205946A (zh) 2017-09-26
MX2017002700A (es) 2017-08-28
BR112017003425A2 (pt) 2017-11-28
CN115721651A (zh) 2023-03-03
US20170252346A1 (en) 2017-09-07
CA2958454A1 (en) 2016-03-03
AU2015309176B2 (en) 2020-12-03
PH12017500345A1 (en) 2017-07-17
JP2017525774A (ja) 2017-09-07
US20190269691A1 (en) 2019-09-05
EP3185861A1 (en) 2017-07-05
WO2016030092A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
SV2017005601A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
EA201890654A1 (ru) Терапевтические композиции для лечения вируса иммунодефицита человека
EA202090683A2 (ru) Способы и композиции для лечения рака
EA201792591A1 (ru) Фармацевтические препараты
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
CY1119532T1 (el) (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
CY1119522T1 (el) (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
EA201691796A1 (ru) П-замещенные асимметричные мочевины и их применение в медицине
MD4763B1 (ru) Фармацевтическая композиция
EA201700254A1 (ru) Комбинация
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
EA201890911A1 (ru) Комбинация тразодона и габапентина для лечения боли
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний
EA201790387A1 (ru) Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти
EP3880171C0 (en) ORAL PHARMACEUTICAL FORMULATION CONTAINING IBUPROFEN
EA201892095A1 (ru) Циклические динуклеотидные соединения и способы их применения
MX2014008984A (es) Proceso de obtencion y composicion farmaceutica de fenofibrato capsulas como agente regulador de lipidos para su administracion oral.
UA88138U (ru) Лекарственное средство в форме перорального раствора для лечения и профилактики ишемии тканей организма